Predictors of use of complementary and alternative medicine by non-Hodgkin lymphoma survivors and relationship to quality of life

Integrative Cancer Therapies

Volumn 12, Issue 3, 2013, Pages 225-235

  Hamilton, Ann S ^a   Miller, Melissa F ^b   Arora, Neeraj K ^c   Bellizzi, Keith M ^d   Rowland, Julia H ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Uniting the Wellness Communities and Gilda's Club Worldwide   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

cancer survivors; complementary and alternative medicine; mental health; non Hodgkin lymphoma; perceived control

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER CONTROL; CANCER REGISTRY; CANCER SURVIVOR; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NONHODGKIN LYMPHOMA; PERCEIVED PERSONAL CONTROL SCALE; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SHORT FORM 36; SOCIAL MEDICINE;

AGED; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; LOS ANGELES; LYMPHOMA, NON-HODGKIN; MALE; MENTAL HEALTH; MIDDLE AGED; QUALITY OF LIFE; SURVIVORS;

EID: 84874010061     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412449733     Document Type: Article

References (45)

1. RiesLAGMelbertDKrapchoM, eds. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008. http://seer.cancer.gov/csr/1975- 2005/. Accessed May 30, 2012.
2. Ernst E. The current position of complementary/alternative medicine in cancer. Eur J Cancer. 2003 ; 39: 2273-2277
3. AltekruseSKosaryCKrapchoM, eds. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975-2007/. Accessed May 30, 2012.
4. Habermann TM, Thompson CA, LaPlant BR, et al. Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol. 2009 ; 84: 795-798
5. Arora N, Bellizzi K, Rowland J, Potosky A, Aziz N, Hamilton A. Health-related quality of life of survivors of non-Hodgkin's lymphoma: results from the Experience of Care and Health Outcomes of Survivors of NHL (ECHOS-NHL) study. Psychooncology. 2006 ; 15 (suppl 1). S32 - S23
6. Sparber A, Bauer L, Curt G, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000 ; 27: 623-630
7. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000 ; 18: 2505-2514
8. Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000 ; 18: 2515-2521
9. Burstein H. Discussing complementary therapies with cancer patients: what should we be talking about?. J Clin Oncol. 2000 ; 18: 2501-2504
10. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005 ; 4: 274-286
11. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000 ; 89: 873-880
12. Hamilton A, Cockburn M, Chen X, Deapen D. Factors associated with the use of complementary and alternative medicine by cancer patients in Los Angeles County. J Cancer Integr Med. 2005 ; 3: 51-61
13. Lengacher CA, Bennett MP, Kip KE, Gonzalez L, Jacobsen P, Cox CE. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2006 ; 33: 97-104
14. Arora NK, Hamilton AS, Potosky AL, et al. Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv. 2007 ; 1: 49-63
15. Wyatt G, Sikorskii A, Wills CE, Su H. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res. 2010 ; 59: 58-66
16. Saini A, Berruti A, Capogna S, et al. Prevalence of complementary/ alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. Qual Life Res. 2011 ; 20: 683-690
17. Owens B. A test of the self-help model and use of complementary and alternative medicine among Hispanic women during treatment for breast cancer. Oncol Nurs Forum. 2007 ; 34: E42 - E50
18. Bellizzi KM, Miller MF, Arora NK, Rowland JH. Positive and negative life changes experienced by survivors of non-Hodgkin's lymphoma. Ann Behav Med. 2007 ; 34: 188-199
19. Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2008 ; 113: 1048-1057
20. Mueller CM, Mai PL, Bucher J, Peters JA, Loud JT, Greene MH. Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer. BMC Complement Altern Med. 2008 ; 8: 17
21. Jones R, Taylor AG, Bourguignon C, et al. Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors. Oncol Nurs Forum. 2007 ; 34: 359-364
22. Jones L, Demark-Wahnefried W. Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol. 2006 ; 7: 1017-1026
23. Owen JE, Goldstein MS, Lee JH, Breen N, Rowland JH. Use of health-related and cancer-specific support groups among adult cancer survivors. Cancer. 2007 ; 109: 2580-2589
24. Ganz P, Desmond K, Leedham B, Rowland J, Meyerowitz B, Belin T. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002 ; 94: 39-49
25. Sherbourne C, Stewart A. The MOS social support survey. Soc Sci Med. 1991 ; 32: 705-714
26. Arora NK, Weaver K, Clayman M, Oakley-Girvan I, Potosky A. Physician's decision-making style and psychosocial outcomes among cancer survivors. Patient Educ Couns. 2009 ; 77: 404-412
27. Affleck G, Tennen H, Pfeiffer C, Fifield J. Appraisals of control and predictability in adapting to a chronic illness. J Pers Soc Psychol. 1987 ; 53: 273-279
28. Manne S, Glassman M. Perceived control, coping efficacy, and avoidance coping as mediators between spouses' unsupportive behaviors and cancer patients' psychological distress. Health Psychol. 2000 ; 19: 155-164
29. Scheier M, Carver C, Bridges M. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994 ; 67: 1063-1078
30. Ware JJ, Kosinski M, Dewey J How to Score Version 2 of the SF-36® Health Survey. Lincoln, RI: QualityMetric Incorporated ; 2000 :
31. Ware JJ, Kosinski M, Gandek B SF-36® Health Survey: Manual & Interpretation Guide. Lincoln, RI: QualityMetric Incorporated ; 2000 :
32. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 ; 51: 1173-1182
33. Arora NK, Johnson P, Gustafson DH, McTavish F, Hawkins RP, Pingree S. Barriers to information access, perceived health competence, and psychosocial health outcomes: test of a mediation model in a breast cancer sample. Patient Educ Couns. 2002 ; 47: 37-46
34. Barnes P, Powell-Griner E, McFann K, Nahin R. Complementary and alternative medicine use among adults: United States, 2002. Adv Data Vital Health Stat. 2004 ; 343: 1-20
35. Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER. The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psychooncology. 2008 ; 17: 19-25
36. Richardson M, Strauss S. Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol. 2002 ; 29: 531-545
37. Luckett T, King M, Butow P, Friedlander M, Paris T. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change. Int J Gynecol Cancer. 2010 ; 20: 664-684
38. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000 ; 92: 42-47
39. Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support Care Cancer. 2009 ; 17: 333-337
40. Smith KB, Pukall CF. An evidence-based review of yoga as a complementary intervention for patients with cancer. Psychooncology. 2009 ; 18: 465-475
41. Cassileth BR, Gubili J, Simon Yeung K. Integrative medicine: complementary therapies and supplements. Nat Rev Urol. 2009 ; 6: 228-233
42. Sagar SM, Lawenda BD. The role of integrative oncology in a tertiary prevention survivorship program. Prev Med. 2009 ; 49: 93-98
43. Carlson LE, Bultz BD. Mind-body interventions in oncology. Curr Treat Options Oncol. 2008 ; 9: 127-134
44. Mallik A, Leonard JP. Reality of complementary and alternative medicine in lymphoma patients: hope, hype, or help?. Am J Hematol. 2009 ; 84: 785-787
45. Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns. 2010 ; 79: 143-151